In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Immunovant Inc (NASDAQ: IMVT) closed at $14.10 down -1.33% from its previous closing price of $14.29. In other words, the price has decreased by -$1.33 from its previous closing price. On the day, 1.43 million shares were traded.
Ratios:
For a deeper understanding of Immunovant Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 21 ’25 when GEORGE V MIGAUSKY bought 21,812 shares for $14.58 per share.
GEORGE V MIGAUSKY bought 28,188 shares of IMVT for $410,908 on May 19 ’25. On Apr 23 ’25, another insider, Stout Jay S, who serves as the Chief Technology Officer of the company, sold 1,925 shares for $14.79 each. As a result, the insider received 28,471 and left with 209,243 shares of the company.
Stock Price History:
Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is -9.23%, while the 200-Day Moving Average is calculated to be -40.63%.
Shares Statistics:
A total of 147.20M shares are outstanding, with a floating share count of 68.14M. Insiders hold about 59.89% of the company’s shares, while institutions hold 56.01% stake in the company.
